Information Provided By:
Fly News Breaks for March 31, 2017
ANGO
Mar 31, 2017 | 08:35 EDT
Craig-Hallum analyst Charles Haff says that despite reporting revenue that was below his estimate, he believes the turnaround story at AngioDynamics remains intact, as profitability continues to trend in the right direction with EPS better than he expected. The analyst reiterates a Buy rating and $20 price target.
News For ANGO From the Last 2 Days
There are no results for your query ANGO